Your browser doesn't support javascript.
loading
Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial.
Ahmadi, Majid; Aghdam, Sanaz Abbaspour; Nouri, Mohammad; Babaloo, Zohreh; Farzadi, Laya; Ghasemzadeh, Aliye; Hamdi, Kobra; Movassaghpour, Ali Akbar; Jadidi-Niaragh, Farhad; Afkham, Amir; Motallebnezhad, Morteza; Eghbal-Fard, Shadi; Dolati, Sanam; Younesi, Vahid; Yousefi, Mehdi.
Afiliação
  • Ahmadi M; Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student's Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School o
  • Aghdam SA; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Nouri M; Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; Reproductive Biology Department, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Babaloo Z; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Farzadi L; Reproductive Biology Department, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ghasemzadeh A; Reproductive Biology Department, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hamdi K; Reproductive Biology Department, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Movassaghpour AA; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Jadidi-Niaragh F; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Afkham A; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Motallebnezhad M; Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Eghbal-Fard S; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Dolati S; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Younesi V; Pishtaz Teb Diagnostics, Tehran, Iran.
  • Yousefi M; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Yousefime@tbzmed.ac.ir.
Immunol Lett ; 192: 12-19, 2017 12.
Article em En | MEDLINE | ID: mdl-29030251
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Sanguíneas / Aborto Habitual / Imunoglobulinas Intravenosas / Linfócitos T Reguladores / Células Th17 / Imunoterapia Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Sanguíneas / Aborto Habitual / Imunoglobulinas Intravenosas / Linfócitos T Reguladores / Células Th17 / Imunoterapia Idioma: En Ano de publicação: 2017 Tipo de documento: Article